This incretin effect is considerably attenuated in people with type 2 diabetes (see Figure 1), a loss that is even considered an early indicator of the disease, but it was observed that this deficit could be completely corrected by the continuous infusion of GLP-1 to diabetic patients
doi: 10.1016/j.clinthera.2017.01.005 248
J.ChungB
The Teladoc medical history form does not ask a dedicated family-history MEN-2 or medullary thyroid cancer screen, does not ask the eating-disorder question, does not ask pregnancy or breastfeeding status, does not include a validated PHQ-2 depression instrument (anxiety and panic attacks are on the Health Problems checklist, but not the standard past 2 weeks screening items), and does not capture blood pressure or resting heart rate
No available OTC without a prescription Who It's For Adults 18+ not on insulin GLP-1 users, type 2, prediabetes, health-focused Wear Time 15 days longest biosensor wear time on the market Price $99 / 2-pack (30-day supply) or $89/month subscription Insurance HSA/FSA eligible
